Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
暂无分享,去创建一个
P. Warde | L. Looijenga | Philippe Bédard | A. Hansen | A. Gillis | P. Chung | E. Atenafu | M. Jewett | R. Hamilton | L. Anson-Cartwright | J. Lobo | J. Sweet | M. O'Malley | K. Kuhathaas | R. Leão | A. van den Berg